http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108863923-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
filingDate 2018-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108863923-B
titleOfInvention Pyridone derivative and preparation method and application thereof
abstract The invention discloses a pyridone derivative, a preparation method and application thereof, wherein the pyridone derivative is mainly prepared from R 1 ,R 2 ,R 3 Structural modifications of these three substituents are made, wherein R 1 The modification of (A) is mainly carried out by allyl, isopentenyl, geranyl, p-fluorobenzyl and the like; r 2 The modification of (a) is mainly by hydroxyethyl, hydroxypropyl, aminoethyl, aminopropyl, etc.; r 3 The modification (c) is mainly focused on ethers with certain structural features. The pyridone derivative has obvious inhibition effect on pancreatic cancer cells PANC-1 in a poor nutrition state, and has no influence on the cells in a normal nutrition state (no cytotoxicity is suggested). The preparation method of the pyridone derivative firstly synthesizes basic parent nucleus bicyclo [3.3.1]Nonanone is subjected to rearrangement reaction with a series of alcohol amines or diamines under the catalysis of toluenesulfonic acid to prepare para-pancreasThe pyridone derivative has obvious cancer inhibiting effect and high practicability.
priorityDate 2018-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426081674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415739327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425154543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415753224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID521998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447686356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422808907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20565003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410746595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID549585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450273274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449495704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415836460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76546169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415716027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416005937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5365867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53627726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415787828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64981

Total number of triples: 66.